Tardive dyskinesia: Who gets it and why
Author:
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 59, 151-154
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Oxidative stress and tardive dyskinesia: Pharmacogenetic evidenceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2013
- Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesisMovement Disorders, 2012
- Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic MedicationsThe Journal of Clinical Psychiatry, 2010
- Association of the HSPG2 Gene with Neuroleptic-Induced Tardive DyskinesiaNeuropsychopharmacology, 2010
- The DRD3 rs6280 polymorphism and prevalence of tardive dyskinesia: A meta‐analysisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009
- A candidate gene study of tardive dyskinesia in the CATIE schizophrenia trialAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009
- Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patientsMolecular Psychiatry, 2007
- Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trialSchizophrenia Research, 2005
- Metoclopramide‐induced tardive dyskinesia in an infantMovement Disorders, 2004
- Antipsychotic-Induced Movement Disorders in the ElderlyDrugs & Aging, 2000